Introduction
Esophageal cancer (EC) is a common malignancy, rankingsixthinallcancerdeathcausesworldwide(1)andthirdin China (2) .In2015,theprevalencerateofECwasestimatedto be477,900,andECcaused375,000deathsinChina.InWestern countries,themajorhistologicaltypeofesophagealcanceris adenocarcinoma(AC),whileinChina,esophagealsquamouscell carcinoma(ESCC)isthedominanttype (2) .PatientswithESCC usuallyhaveapoorprognosis.Despitethevarious advancesin multimodaltreatmentstrategy,the5-yearoverallsurvivalrate isstillonly15%-25%.Tooptimizethetreatmentstrategy,itis criticaltoidentifythosepatientswithworseprognosis.
The prognosis of ESCC patients has been reported to be correlated with age, TNM stage, metastasis and tumor clinicalrecordsofpatients,ithasthepotentialtobeusedasa practicalprognosticbiomarkerforcancerpatients.Thecutoff valueandpredictivevalueofNLRhavebeentestedinvariousstudies (15, 16) .However,inESCCpatients,onlyalimited numberofstudieshavebeencarriedouttotestthecorrela-tionofNLRwithpatients'prognosis (17) (18) (19) .Inaddition,due tothedifferencesinethnicandgeographicaloriginsamong patients, the predictive value of NLR needs to be tested in differentpopulations.Therefore,thecurrentstudyaimedto determinethecorrelationofNLRwithoverallsurvivalofESCC patientsinChina. 
Method

Study design and patients
Intervention
Theclinicaltreatmentregimenswerechosenaccording totheguidelinesfortreatmentofEC(Chineseversion).Most patients underwent esophagectomy surgery with cisplatin plus5-fluorouracilregimenand/orintensity-modulatedradiationtherapy(IMRT)asadjuvanttherapyorneoadjuvant therapy.
Outcome measurement and data extraction
The study mainly aimed to analyze the correlation between NLR and overall survival of ESCC patients. Overall survivalwasdefinedasthetimefromthedayoftreatment initiation-whethersurgery,chemotherapyorradiotherapy (whichever was carried out first) -until the date of confirmed death. Patients with records of being alive at the lastavailablefollow-upwereconsideredascensoreddata.
Neutrophilandlymphocytecountsatdiagnosticexamination were extracted from the clinical records. The NLR was calculated by dividing the absolute neutrophil count by the absolutelymphocytecount.
Inaddition,patients'characteristicssuchasage,sex, tumor staging, carcinoembryonic antigen (CEA), albumin (ALB) and globulin(GLB)werecollectedfromtheclinicalrecords.
Follow-up
Thepatientswereregularlyfollowedupevery3months forthefirst18monthsthroughrevisitsorphonecallsafter initiation of treatment. After 18 months, patients were fol-lowedupevery6monthsthroughphonecalls.Insomecases, additionalfollow-updatawerecollectedthroughaphonecall duringthestudyprocess.
Statistical analysis
SPSSversion17.0(SPSSInc.,Chicago,IL,USA)wasused forstatisticalanalysisinthecurrentstudy.A2-sidedpvalue <0.05wasconsideredtobestatisticallysignificant.Continu-ousdatawereexpressedasmeans±standarddeviation(SD). Categorical data were expressed as frequency, ratio or percentage. Overall survival of patients was analyzed with Kaplan-Meier survival curves. Univariate and multivariate Cox regression analysis was used to determine the correlations betweenNLR,aswellasbaselinecharacteristics,withoverall survival.Thelog-ranktestwasusedtocomparesurvivalbetweendifferentpatientpopulations.
Results
Baseline demographics and clinical characteristics
A total of 1,281 patients were included in the current study,with988menand293women.Thedetailedbaseline characteristics of patients are listed in Table I . The surviv-ingESCCpatientsattheendoffollowed-up(survivalgroup) were significantly younger than those who died (deceased group)duringfollow-up(age57.7±8.9vs.60.2±27.7,p= 0.028).SerumlevelsofCEAinthesurvivalgroupwere2.9± 2.8 ng/mL, significantly lower than those of the deceased group(3.5±3.5ng/mL,p=0.006).
To analyze the relationship between NLR and disease outcome, the patients were chronologically divided into training group (n = 727) and validation group (n = 554). NLRswerecalculatedamongallESCCpatientsenrolled.In thetraininggroup,NLRsweresignificantlylowerinthesurvival group (2.4 ± 0.9) than in the deceased group (3.3 ± 1.6,p<0.001).Asimilartrendwasobservedinthevalidationgroup(p<0.001).Inpatientsoverall,NLRwaslowerin thesurvivalgroupthaninthedeceasedgroup(2.4±0.9vs. 3.4±1.7; Fig.1 ). Values are means ± standard deviation, or number, as indicated. ALB = albumin; CEA = carcinoembryonic antigen; GLB = globulin. Fig. 1 -Differentneutrophiltolymphocyteratio(NLR) 
Factors associated with NLR
Association of NLR and clinical outcomes
TodeterminetheprognosticimpactofNLRonESCCpatients,Kaplan-Meiersurvivalanalysiswasperformed.Inthe training group, Kaplan-Meier analysis indicated that ESCC Values are means ± standard deviation, or number, as indicated. ALB = albumin; CEA = carcinoembryonic antigen; GLB = globulin.
patients with high NLR were associated with significantly worseprognosis,intermsofoverallsurvivalrate(p<0.001). Consistently, low NLR was positively correlated with favorable overall survival outcome in the validation cohort (p<0.001). In line with the training and validation groups, theresultsintheoverallgroupindicatedthatESCCpatients withhighNLRwerelikelytohaveloweroverallsurvivalrates ( Fig.2) . Stratifiedsurvivalanalyseswereconductedtofurtherre-vealtheprognosticsignificanceofNLR.DatashowedthatNLR wasassociatedwithoverallsurvivalinmaleandfemaleESCC patients,inESCCpatientswithwell-moderateandpoor-undifferentiateddifferentiation,andinpatientswithTNMstage I-II and TNM stage III-IV disease ( Supplementary Figure 1 , available online at www.biological-markers.com -Stratified survivalanalysesofprognosticvalueofNLR).
Analysis of the independent factors for overall survival
Cox regression analysis was used to determine correlationsofage,sex,TNMstage,tumorlocation,differentiation, ALB, GLB, CEA and NLR with overall survival. As shown in Table III , univariate analysis detected age, CEA, tumor size, tumordifferentiation,TNMstageandNLRascorrelatedfactors for overall survival. While in multivariate analysis, age (hazard ratio [HR] = 1.002, 95% CI, 1.000-1.005; p = 0.03), CEA(HR=1.039,95%CI,1.013-1.065;p=0.003),tumorsize (HR = 1.057, 95% CI, 1.006-1.111; p = 0.028), TNM staging (HR = 2.172, 95% CI, 1.796-2.628; p<0.001) and NLR (HR = 1.892,95%CI,1.567-2.284,p<0.001)wereidentifiedasindependentfactorscorrelatedwithoverallsurvival.
Inaddition,areceiveroperatorcharacteristic(ROC)curve analysiswasconductedtoverifytheprognosticandpredic-tivecapabilityofNLR(SupplementaryFigure2,availableonlineatwww.biological-markers.com-ROCcurveanalysisto verifytheprognosticvalueofNLR).Theresultsindicatedthat the area under ROC curve was 0.687 (95% CI, 0.656-0.717; p<0.001), the sensitivity was 54.2% and the specificity was 74.3%,whentheNLRcutoffvaluewassetto>2.91.
Discussion
Theresultsofthecurrentstudyshowedthatinpatients diagnosed with ESCC in our center, the overall survival was associated with NLR, as well as with other recognized risk factors including age and TNM stage. Patients with higher pretreatment NLR had worse prognosis in terms of overall survivalcomparedwiththosewithlowerNLR.Theseresults demonstratedthatNLRmaybeusedasaprognosticpredic-torforESCCandapotentialtargetfortherapydevelopment. ESCC has much a greater prevalence in the male populationthaninthefemalepopulation,especiallyinChina (2) .Differences in smoking habits may account for the imbalanced morbidityinthedifferentsexes.Inthecurrentstudy,menac-countedforabout77%ofthetotalstudysubjects.Thisproportion is consistent with previous studies of ESCC in a Chinese population (19, 20) .Inthecurrentstudy,sexwasnot identifiedasanindependentfactorcorrelatedwithoverallsurvival ofESCC.Thismaybeduetotherelativelysmallsamplesizeand inefficientfemalepatientsamplesize.Therefore,theimpactof thesexofapatientonoverallsurvivalwithESCCneedstobe furtherconfirmedinfuturestudies.Inaddition,patients'characteristicssuchasthedistributionofcancerstages,tumorlocationanddifferentiationstatuswereallconsistentwithprevious studies.Theseresultsindicatethatthegeneralclinicalfeatures ofChineseESCCpatientsindifferentregionsmightnotbesignificantlydifferent.Therefore,theresultsofthisstudymaybe usedasareferenceinothersimilarstudiesinESCCpatientsof China.
Thereisastronglinkagebetweencancerandinflammation (9, 21, 22) .Inflammationcannotonlyaffecttheoutcome ofaseriesofdiseases,butcanalsoaffecttheoccurrenceand development of tumors (23) (24) (25) (26) . Serum markers including neutrophils, platelets and lymphocytes and others derived fromtheperipheralbloodhavebeenproventobesignificantlyassociatedwithaseriesofdiseasesandtumorprogression (27) (28) (29) (30) . Some indicators such as the systemic immune-inflammationindex(SII)andplatelettolymphocyteratio(PLR) haveemergedasprognosticfactorsinmanycancers,includ-ingESCC (31, 32) .Inthecurrentstudy,werevealedthatpre-treatmentNLRwassignificantlyassociatedwithprognosisof ESCC.Howtocombinetheseinflammatoryparametersinto1 equationtoprovidemoreaccurateprognosticpredictionsfor ESCCrequiresfurtherstudy.
NLR has been reported to be correlated with patients' prognosis in different cancer studies. It has been reported that the pretreatment median NLR ranged from about 1.5 to3.3 (13, 14, 33) .Forexample,ithasbeenreportedthata medianpreoperativeNLRof2.1wasofsignificantprognostic valuefordisease-specificmortalityinESCCpatientswhounderwentsurgery (34) .Invariouscancerpatients,ithasbeen shownthatNLRcutoffsrangingfrom1.9to4.2wereofsignificantpredictivevaluefortreatmentresponses (12, 18, 35) . Inthecurrentstudy,themedianpretreatmentNLRinESCC patientswasestimatedtobe2.3.Thisresultisconsistentwith previousstudies.Variousstudiesindifferentpatientpopulations haveidentified a relativelysmall variation in pretreatment NLR. These results indicate that NLR may be a stable characteristicandthereforemayhavepracticalvalueinprognosticpredictionofpatients'outcome.
Thecurrentstudy had some limitations. Firstly,this was a relatively small sample size retrospective study with limited statistical power. Due to considerations of data intactness,onlyoverallsurvival,andnotprogression-freesurvival orotherpatient outcomes,was analyzed. Also,someother baseline characteristics, variations in therapy regimens, as wellasinteractionsbetweenvariablesmayhavecausedbias intheresults.Despitethis,theresultsindicatedthatNLRhas ahighprobabilitytobeusefulasapredictivemarkerforthe prognosisofESCCpatients.
Inconclusion,resultsfromthecurrentstudyshowedthat pretreatmentNLRwasindependentlyassociatedwithoverall survival of ESCC patients. Therefore, NLR may be used as a predictiveindicatorforthepretreatmentevaluationandadjustmentoftreatmentregimen.
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